{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:13:37Z","timestamp":1784740417813,"version":"3.55.0"},"reference-count":34,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Ankylosing Spondylitis (AS) is associated with increased cardiovascular disease risk due to chronic systemic inflammation. The Atherogenic Index of Plasma (AIP) and Systematic Coronary Risk Evaluation (SCORE) are valuable tools for cardiovascular risk assessment, while Klotho, an anti-aging protein with cardioprotective properties, may serve as a potential biomarker for cardiovascular health. Recent studies have shown that soluble \u03b1-Klotho contributes to vascular protection by increasing endothelial cell proliferation, reducing apoptosis, and enhancing angiogenic capacity, thereby helping to maintain microvascular integrity. We aimed to assess cardiovascular event risk in AS patients using AIP and SCORE and investigate the relationship between serum Klotho levels and these factors. Methods: A case\u2013control study was conducted between August and September 2019. The study included 24 AS patients and 24 healthy controls aged 18 and above, with 13 females and 11 males. Results: No significant difference was found in serum Klotho levels between the AS and control groups in terms of SCORE and AI classifications. In the high-risk SCORE classification group, AI was found to be elevated at 0.42. In the AS group, Klotho levels were observed as 0.73 in the low-risk group, 0.60 in the moderate-risk group, and 0.61 in the high-risk group (p = 0.974). When evaluating HDL levels, Klotho was determined to be 7.29 \u00b1 6.81 for HDL &lt; 35 and 0.60 [0.33] for HDL \u2265 35 (p = 0.036). Conclusions: An AI exceeding 0.40 in the high-risk SCORE group and in patients with active disease according to the BASDAI score indicated an increased cardiovascular event risk in the AS group. Further studies are warranted regarding serum Klotho levels, HDL, and LDL subclasses in AS patients.<\/jats:p>","DOI":"10.3390\/jcm15010131","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:22:27Z","timestamp":1766578947000},"page":"131","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of Cardiovascular Risk and Examination of Blood Klotho Levels in Patients with Ankylosing Spondylitis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3817-7560","authenticated-orcid":false,"given":"Burcu","family":"Dogan","sequence":"first","affiliation":[{"name":"Department of Family Medicine, Gulhane Faculty of Medicine, University of Health Sciences, Ankara 06010, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9078-6996","authenticated-orcid":false,"given":"Aysel","family":"Tocoglu","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Internal Medicine, Sakarya University Training and Research Hospital, Sakarya 54100, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8859-934X","authenticated-orcid":false,"given":"Sabah","family":"Tuzun","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Haseki Training and Research Hospital, Istanbul 34096, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulku","family":"Akcay","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Internal Medicine, Sakarya University Training and Research Hospital, Sakarya 54100, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayfer","family":"Altas","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Internal Medicine, Sakarya University Training and Research Hospital, Sakarya 54100, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6990-4206","authenticated-orcid":false,"given":"Emel","family":"Gonullu","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Sakarya University Training and Research Hospital, Sakarya 54100, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2005-0737","authenticated-orcid":false,"given":"Ali","family":"Tamer","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Internal Medicine, Sakarya University Training and Research Hospital, Sakarya 54100, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1093\/rheumatology\/keae080","article-title":"Risk of cardiovascular disease decreases over time in psoriatic arthritis but not in spondylarthritis: Meta-analysis of longitudinal studies","volume":"63","author":"Gouze","year":"2024","journal-title":"Rheumatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/BOR.0000000000000999","article-title":"Cardiovascular disease in spondyloarthritis: A narrative review of risk factors and the effect of treatments","volume":"36","author":"Sen","year":"2024","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/acr.20364","article-title":"Cardiovascular profile in ankylosing spondylitis: A systematic review and meta-analysis","volume":"63","author":"Mathieu","year":"2011","journal-title":"Arthritis Care Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.semarthrit.2014.10.007","article-title":"Cardiovascular events in ankylosing spondylitis: An updated meta-analysis","volume":"44","author":"Mathieu","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.3899\/jrheum.150316","article-title":"Subclinical Atherosclerosis Is Not Accelerated in Patients with Ankylosing Spondylitis with Low Disease Activity: New Data and Metaanalysis of Published Studies","volume":"42","author":"Arida","year":"2015","journal-title":"J. Rheumatol."},{"key":"ref_6","unstructured":"Wenker, K., and Quint, J. (2023). Ankylosing Spondylitis. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_8","first-page":"zwaf013","article-title":"Risk stratification for cardiovascular disease: A comparative analysis of cluster analysis and traditional prediction models","volume":"32","author":"Zhou","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2021.03.009","article-title":"Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors","volume":"324","author":"Won","year":"2021","journal-title":"Atherosclerosis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1532-5415.2011.03558.x","article-title":"Plasma klotho and cardiovascular disease in adults","volume":"59","author":"Semba","year":"2011","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cca.2006.02.021","article-title":"Klotho gene polymorphism may be a genetic risk factor for atherosclerotic coronary artery disease but not for vasospastic angina in Japanese","volume":"371","author":"Imamura","year":"2006","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jcmm.12710","article-title":"Influence of Klotho gene polymorphisms on vascular gene expression and its relationship to cardiovascular disease","volume":"20","year":"2016","journal-title":"J. Cell Mol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bbrc.2010.11.045","article-title":"Association of the functional KL-VS variant of Klotho gene with early-onset ischemic stroke","volume":"403","author":"Majumdar","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13075-017-1233-0","article-title":"Proangiogenic effects of soluble \u03b1-Klotho on systemic sclerosis dermal microvascular endothelial cells","volume":"19","author":"Mazzotta","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"406960","DOI":"10.1155\/2014\/406960","article-title":"Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension","volume":"2014","author":"Dinh","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.CIR.0000124224.48962.32","article-title":"Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression","volume":"109","author":"Takeshita","year":"2004","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/2012.jama.10503","article-title":"Aortic stiffness, blood pressure progression, and incident hypertension","volume":"308","author":"Kaess","year":"2012","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/heartjnl-2013-304746","article-title":"Reduced Klotho is associated with the presence and severity of coronary artery disease","volume":"100","year":"2014","journal-title":"Heart"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jacc.2010.12.017","article-title":"Aortic stiffness: Current understanding and future directions","volume":"57","author":"Cavalcante","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3892\/etm.2016.3996","article-title":"Activation of peroxisome proliferator-activated receptor \u03b3 inhibits vascular calcification by upregulating Klotho","volume":"13","author":"Cheng","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/ndt\/gfq537","article-title":"Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy","volume":"26","author":"Yoon","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/ckj\/sfaa100","article-title":"Klotho: A link between cardiovascular and non-cardiovascular mortality","volume":"13","author":"Lanzani","year":"2020","journal-title":"Clin. Kidney J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1681\/ASN.2014040325","article-title":"Soluble Klotho protects against uremic cardiomyopathy independently of fibroblast growth factor 23 and phosphate","volume":"26","author":"Xie","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"Valkenburg","year":"1984","journal-title":"Arthritis Rheum."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Sofogianni, A., Stalikas, N., Antza, C., and Tziomalos, K. (2022). Cardiovascular Risk Prediction Models and Scores in the Era of Personalized Medicine. J. Pers. Med., 12.","DOI":"10.3390\/jpm12071180"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s10067-018-4027-0","article-title":"Atherogenic index of plasma: A useful marker for subclinical atherosclerosis in ankylosing spondylitis: AIP associate with cIMT in AS","volume":"37","author":"Cure","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"ref_28","first-page":"64","article-title":"AIP\u2013atherogenic index of plasma as a significant predictor of cardiovascular risk: From research to practice","volume":"52","author":"Dobiasova","year":"2006","journal-title":"Vnitr. Lek."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4331\/wjbc.v6.i4.351","article-title":"Klotho in cardiovascular disease: Current and future perspectives","volume":"6","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/hc0302.102575","article-title":"Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular M\u00fcnster (PROCAM) study","volume":"105","author":"Assmann","year":"2002","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Jiang, S., Wang, Y., Wang, Z., Zhang, L., Jin, F., and Li, B. (2023). The association of serum Klotho concentrations with hyperlipidemia prevalence and lipid levels among US adults: A cross-sectional study. BMC Public Health, 23.","DOI":"10.1186\/s12889-023-16566-y"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kanda, E., Ai, M., Okazaki, M., Yoshida, M., and Maeda, Y. (2016). Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166459"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"11245","DOI":"10.1038\/s41598-025-96090-8","article-title":"Association between the atherogenic index of plasma and the systemic immuno-inflammatory index using NHANES data from 2005 to 2018","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1759720x211033755","DOI":"10.1177\/1759720X211033755","article-title":"Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis","volume":"13","author":"Genre","year":"2021","journal-title":"Ther. Adv. Musculoskelet. Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/131\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:42:39Z","timestamp":1766580159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15010131"],"URL":"https:\/\/doi.org\/10.3390\/jcm15010131","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]}}}